healthŌme and GalenusRx Forge Strategic Partnership to Launch Genomics-based Personalized Medication Safety Program
GalenusRx’s APPRAISE™ Medication Safety Analytics platform helps hospitals deliver accountable, high-quality care that prevents readmissions and reduces financial risk.
The power comes through its precision.
APPRAISE assesses and addresses the full scope of complex medication challenges, including multi-drug, drug-disease, and drug-gene interactions.
No other medication safety platform delivers as comprehensive a combination of holistic data, refined risk analysis, and actionable, evidence-based insights.
No other platform gives pharmacy teams the tools needed to fully implement informed, proactive prevention.
Pharmacists are leaders in the care team, enhancing coordination across all prescribing physicians. With APPRAISE, you’ll go beyond traditional medication reconciliation by adopting a structured, reliable solution for predictive, precise, personalized medication safety reviews.
You’ll empower your pharmacy team to lead in improving care and reducing costs in accountable care relationships mandated by the CMS TEAM program.
Access the data and insights needed to prevent avoidable readmissions and ED visits.
Improve Quality Measures to primary care with optimized, patient-centered strategies.
Enable quicker patient recovery with precise, personalized medication regimens.
Measurably improve CMS quality metrics, including the Patient Safety and Adverse Events Composite and the All-Cause Readmission Measure.
Ensure your hospital is prepared to excel under the TEAM program’s mandates for cost reduction and outcome improvements.
Founded in 2023 by a team of internationally recognized healthcare leaders, GalenusRx is the world’s most advanced medication safety assessment organization.
